145 related articles for article (PubMed ID: 15886808)
21. Complementary roles of glycoprotein VI and alpha2beta1 integrin in collagen-induced thrombus formation in flowing whole blood ex vivo.
Kuijpers MJ; Schulte V; Bergmeier W; Lindhout T; Brakebusch C; Offermanns S; Fässler R; Heemskerk JW; Nieswandt B
FASEB J; 2003 Apr; 17(6):685-7. PubMed ID: 12586747
[TBL] [Abstract][Full Text] [Related]
22. Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion.
Jung SM; Takemura Y; Imamura Y; Hayashi T; Adachi E; Moroi M
Platelets; 2008 Feb; 19(1):32-42. PubMed ID: 18231936
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI.
Nurden AT
Blood Rev; 2019 Nov; 38():100592. PubMed ID: 31351674
[TBL] [Abstract][Full Text] [Related]
24. Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice.
Grüner S; Prostredna M; Koch M; Miura Y; Schulte V; Jung SM; Moroi M; Nieswandt B
Blood; 2005 Feb; 105(4):1492-9. PubMed ID: 15507524
[TBL] [Abstract][Full Text] [Related]
25. Glycoprotein VI but not alpha2beta1 integrin is essential for platelet interaction with collagen.
Nieswandt B; Brakebusch C; Bergmeier W; Schulte V; Bouvard D; Mokhtari-Nejad R; Lindhout T; Heemskerk JW; Zirngibl H; Fässler R
EMBO J; 2001 May; 20(9):2120-30. PubMed ID: 11331578
[TBL] [Abstract][Full Text] [Related]
26. Focusing on plasma glycoprotein VI.
Al-Tamimi M; Arthur JF; Gardiner E; Andrews RK
Thromb Haemost; 2012 Apr; 107(4):648-55. PubMed ID: 22274761
[TBL] [Abstract][Full Text] [Related]
27. Glycoprotein VI (GPVI)-functionalized nanoparticles targeting arterial injury sites under physiological flow.
Levi M; Epshtein M; Castor T; Gawaz M; Korin N
Nanomedicine; 2020 Oct; 29():102274. PubMed ID: 32712174
[TBL] [Abstract][Full Text] [Related]
28. Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.
Jamasbi J; Megens RT; Bianchini M; Münch G; Ungerer M; Faussner A; Sherman S; Walker A; Goyal P; Jung S; Brandl R; Weber C; Lorenz R; Farndale R; Elia N; Siess W
J Am Coll Cardiol; 2015 Jun; 65(22):2404-15. PubMed ID: 26046734
[TBL] [Abstract][Full Text] [Related]
29. Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets.
Arthur JF; Gardiner EE; Matzaris M; Taylor SG; Wijeyewickrema L; Ozaki Y; Kahn ML; Andrews RK; Berndt MC
Thromb Haemost; 2005 Apr; 93(4):716-23. PubMed ID: 15841318
[TBL] [Abstract][Full Text] [Related]
30. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation.
Mammadova-Bach E; Ollivier V; Loyau S; Schaff M; Dumont B; Favier R; Freyburger G; Latger-Cannard V; Nieswandt B; Gachet C; Mangin PH; Jandrot-Perrus M
Blood; 2015 Jul; 126(5):683-91. PubMed ID: 25977585
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and therapeutic potentials of platelet glycoprotein VI.
Bigalke B; Krämer BF; Seizer P; Fateh-Moghadam S; Gawaz M; Lindemann S
Semin Thromb Hemost; 2010 Mar; 36(2):203-11. PubMed ID: 20414836
[TBL] [Abstract][Full Text] [Related]
32. Implications of glycoprotein VI for theranostics.
Gawaz M; Vogel S; Pfannenberg C; Pichler B; Langer H; Bigalke B
Thromb Haemost; 2014 Jul; 112(1):26-31. PubMed ID: 24553806
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation.
Schulz C; Leuschen NV; Fröhlich T; Lorenz M; Pfeiler S; Gleissner CA; Kremmer E; Kessler M; Khandoga AG; Engelmann B; Ley K; Massberg S; Arnold GJ
Blood; 2010 May; 115(20):4102-10. PubMed ID: 20107233
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of receptor shedding-platelet GPVI as an emerging diagnostic and therapeutic tool.
Chatterjee M; Gawaz M
Platelets; 2017 Jun; 28(4):362-371. PubMed ID: 27753514
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression.
Ohlmann P; Hechler B; Ravanat C; Loyau S; Herrenschmidt N; Wanert F; Jandrot-Perrus M; Gachet C
J Thromb Haemost; 2008 Jun; 6(6):1003-11. PubMed ID: 18419749
[TBL] [Abstract][Full Text] [Related]
36. Design and reshaping of an scFv directed against human platelet glycoprotein VI with diagnostic potential.
Zahid M; Loyau S; Bouabdelli M; Aubrey N; Jandrot-Perrus M; Billiald P
Anal Biochem; 2011 Oct; 417(2):274-82. PubMed ID: 21771576
[TBL] [Abstract][Full Text] [Related]
37. Ex vivo evaluation of anti-GPVI antibody in cynomolgus monkeys: dissociation between anti-platelet aggregatory effect and bleeding time.
Matsumoto Y; Takizawa H; Nakama K; Gong X; Yamada Y; Tandon NN; Kambayashi J
Thromb Haemost; 2006 Aug; 96(2):167-75. PubMed ID: 16894460
[TBL] [Abstract][Full Text] [Related]
38. Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase.
Gardiner EE; Arthur JF; Kahn ML; Berndt MC; Andrews RK
Blood; 2004 Dec; 104(12):3611-7. PubMed ID: 15308568
[TBL] [Abstract][Full Text] [Related]
39. Platelet glycoprotein VI: its structure and function.
Moroi M; Jung SM
Thromb Res; 2004; 114(4):221-33. PubMed ID: 15381385
[TBL] [Abstract][Full Text] [Related]
40. EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis.
Grothusen C; Umbreen S; Konrad I; Stellos K; Schulz C; Schmidt B; Kremmer E; Teebken O; Massberg S; Luchtefeld M; Schieffer B; Gawaz M
Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1184-90. PubMed ID: 17347483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
